Pharmanutra S.p.A. (BIT:PHN)
Italy flag Italy · Delayed Price · Currency is EUR
74.70
-1.10 (-1.45%)
At close: Mar 27, 2026

Pharmanutra Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
717521523542601730
Market Cap Growth
39.37%-0.23%-3.62%-9.76%-17.67%100.53%
Enterprise Value
707520523552595710
Last Close Price
74.7054.3053.4154.4759.2470.91
PE Ratio
35.7426.0731.4742.2639.9453.01
Forward PE
29.4023.4725.2532.3638.7953.54
PS Ratio
5.353.894.505.397.2410.71
PB Ratio
10.077.328.409.9711.8016.19
P/TBV Ratio
15.3411.1512.7916.3819.8718.30
P/FCF Ratio
43.6631.7432.16--47.32
P/OCF Ratio
36.6726.6625.5044.8534.4135.76
PEG Ratio
-1.771.771.771.771.77
EV/Sales Ratio
5.283.894.505.497.1610.41
EV/EBITDA Ratio
20.6715.2117.2921.7224.5636.76
EV/EBIT Ratio
23.3317.1719.1124.0025.7838.78
EV/FCF Ratio
43.0531.6832.17--46.00
Debt / Equity Ratio
0.290.290.390.520.350.14
Debt / EBITDA Ratio
0.600.600.791.100.730.33
Debt / FCF Ratio
1.251.251.49--0.41
Net Debt / Equity Ratio
-0.14-0.14-0.080.05-0.18-0.61
Net Debt / EBITDA Ratio
-0.29-0.29-0.160.11-0.38-1.43
Net Debt / FCF Ratio
-0.61-0.61-0.30-2.501.05-1.79
Asset Turnover
1.101.101.010.950.971.11
Inventory Turnover
11.2511.257.537.7610.1315.13
Quick Ratio
1.811.811.951.701.963.08
Current Ratio
2.352.352.382.122.283.32
Return on Equity (ROE)
29.85%29.85%28.39%24.36%31.34%33.26%
Return on Assets (ROA)
15.61%15.61%14.88%13.54%16.82%18.58%
Return on Invested Capital (ROIC)
31.69%33.75%29.08%25.63%50.00%74.25%
Return on Capital Employed (ROCE)
32.20%32.20%30.40%27.20%31.00%33.50%
Earnings Yield
2.79%3.84%3.18%2.37%2.50%1.89%
FCF Yield
2.29%3.15%3.11%-0.21%-1.45%2.11%
Dividend Yield
1.58%2.21%1.87%1.56%1.35%1.00%
Payout Ratio
47.95%47.95%49.20%60.11%45.53%47.10%
Buyback Yield / Dilution
0.40%0.40%0.61%0.05%0.09%-
Total Shareholder Return
1.99%2.61%2.48%1.61%1.44%1.00%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.